ArticleBMC microbiology2025
Quantitative profiling of bacterial communities via full length 16S rRNA gene sequencing with internal controls: optimization and validation across diverse human microbiomes.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccurate estimation of the microbial load is crucial for diagnosing infections and guiding treatment decisions. While traditional culture methods are informative, they are limited by their inability to grow all organisms. Next-generation sequencing offers a more comprehensive alternative for identifying and quantifying microbial communities. This study explored the application of full-length 16S rRNA gene sequencing for bacterial quantification by incorporating internal controls.
methodsWe optimized full-length16S rRNA gene sequencing using nanopore technology, on commercially available mock community standards. We varied DNA input, PCR cycles, and spike-in proportions. The method was then validated using human samples from the stool, saliva, nose, and skin, and a spike-in control for quantification. Community profiling was done with Emu.
resultsEmu performed well at providing genus and species-level resolution. The use of spike-in provided robust quantification across varying DNA inputs and sample origin. However, challenges remained in detecting low-abundance taxa and differentiating closely related species. Human samples with varying microbial loads showed high concordance between sequencing estimates and culture methods.
conclusionThese findings demonstrate that full-length 16S rRNA gene sequencing, combined with spike-ins, offers a reliable and scalable approach for microbial quantification. The method’s performance across diverse human microbiomes supports its potential use in clinical diagnostics where bacterial identification and load estimation are critical. However, further refinement is needed to address limitations in detecting low-abundance and closely related species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.